pillbase.ru

LEQVIO

Active substance: inclisiran

INJECTION, SOLUTION · INCLISIRAN SODIUM 284 mg/1.5mL

United StatesActive

Marketing holder: Novartis Pharmaceuticals Corporation

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Сибрава
    раствор для подкожного введения, 284 мг, 1.5 мл (original in Russian, GRLS)
    ЛП-№(000689)-(РГ-RU)
    Новартис Оверсиз Инвестментс АГ
EU 1
  • Leqvio
    inclisiran
    EMEA/H/C/005333
    Novartis Europharm Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-38bc-71ee-82dd-82c9dbd2528b;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-48a1-7330-a39c-35df6c1c46a2;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0078-1000
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 0078-1000 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0078-1000 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0078-1000 · Verified 2026-10-09 · open in source